相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper
S. Champiat et al.
ANNALS OF ONCOLOGY (2016)
Posterior subcapsular cataracts and hypotony secondary to severe pembrolizumab induced uveitis: Case report
Alfred Basilious et al.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2016)
A case of bilateral uveitis and papillitis in a patient treated with pembrolizumab
Khawla Abu Samra et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2016)
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma
Antoni Ribas et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Clinical Images: Autoimmune arthropathy and uveitis as complications of programmed death 1 inhibitor treatment
Guillermo de Velasco et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Bilateral neuroretinitis and anterior uveitis following ipilimumab treatment for metastatic melanoma
Laura Hahn et al.
JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION (2016)
Corticosteroids and immune checkpoint blockade
Le Min et al.
AGING-US (2015)
New-onset uveitis during CTLA-4 blockade therapy with ipilimumab in metastatic melanoma patient
Elisabetta Miserocchi et al.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2015)
Pancreatitis Secondary to Anti-Programmed Death Receptor 1 Immunotherapy Diagnosed by FDG PET/CT
Yazan Z. Alabed et al.
CLINICAL NUCLEAR MEDICINE (2015)
Safety of pembrolizumab for the treatment of melanoma
Juan Martin-Liberal et al.
EXPERT OPINION ON DRUG SAFETY (2015)
Efficacy and safety of the anti-PD-1 monoclonal antibody MK-3475 in 411 patients (pts) with melanoma (MEL).
Antoni Ribas et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
Caroline Robert et al.
LANCET (2014)
Outcomes of Changing Immunosuppressive Therapy after Treatment Failure in Patients with Noninfectious Uveitis
Lavnish Joshi et al.
OPHTHALMOLOGY (2014)
Difluprednate 0.05% Versus Prednisolone Acetate 1% for Endogenous Anterior Uveitis: A Phase III, Multicenter, Randomized Study
John D. Sheppard et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)
Safety and Tumor Responses with Lambrolizumab (Anti-PD-1) in Melanoma
Omid Hamid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab
Jeffrey S. Weber et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Constitutive Neuronal Expression of the Immune Regulator, Programmed Death 1 (PD-1), Identified During Experimental Autoimmune Uveitis
Ling Chen et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2009)
PD-L1 Expression on Human Ocular Cells and Its Possible Role in Regulating Immune-Mediated Ocular Inflammation
Wanhua Yang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Degree, duration, and causes of visual loss in uveitis
OM Durrani et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2004)
分享论文
